68 Results

People

  1. Iasonos
    Iasonos
  2. Aghajanian
    Aghajanian
  3. Zhou
    Zhou
  4. Abu-Rustum
    Abu-Rustum
  5. Hensley
    Hensley
  6. Sabbatini
    Sabbatini
  7. Chi
    Chi
  8. Konner
    Konner
  9. Spriggs
    Spriggs
  10. Barakat
    Barakat

Groups

  1. Biostatistics Service (68)
  2. Department of Medicine (68)
  3. Epidemiology and Biostatistics (68)
  4. Solid Tumor Oncology Division (68)
  5. Gynecologic Medicine Service (59)
  6. GDMT, Medicine (58)
  7. Gynecology Disease Management Team (58)
  8. Surgery (42)
  9. GDMT, Surgery (33)
  10. GDMT, Pathology and Laboratory Medicine (20)
  1. "adult"
  2. "Solid Tumor Oncology Division"
  3. "Department of Medicine"
  4. "Alexia Iasonos"
Formats
  1. Journal Article (68)
Groups
  1. Biostatistics Service (68)
  2. Department of Medicine (68)
  3. Epidemiology and Biostatistics (68)
  4. Solid Tumor Oncology Division (68)
  5. Gynecologic Medicine Service (59)
  6. GDMT, Medicine (58)

More Groups

People
  1. Alexia Iasonos (68)
  2. Carol Aghajanian (39)
  3. Qin Zhou (36)
  4. Nadeem Abu-Rustum (26)
  5. Martee Hensley (25)
  6. Paul Sabbatini (21)

More People

Years
  1. 2024 (3)
  2. 2023 (7)
  3. 2022 (1)
  4. 2021 (2)
  5. 2020 (4)
  6. 2019 (3)

More Years

Publications
  1. Gynecologic Oncology (33)
  2. Cancer (9)
  3. International Journal of Gynecological Cancer (6)
  4. Clinical Cancer Research (4)
  5. Journal of Clinical Oncology (4)
  6. Annals of Surgical Oncology (2)

More Publications

Publishers
  1. Elsevier Inc. (33)
  2. Wiley Blackwell (9)
  3. Lippincott Williams & Wilkins (6)
  4. American Association for Cancer Research (5)
  5. Springer (5)
  6. American Society of Clinical Oncology (4)

More Publishers

Results (68)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pathogenic germline variants in patients with endometrial cancer of diverse ancestry
    Journal Article

    Liu, Y. L.; Gordhandas, S.; Arora, K.; Rios-Doria, E.; Cadoo, K. A.; Catchings, A.; Maio, A.; Kemel, Y.; Sheehan, M.; Salo-Mullen, E.; more...
    Cancer (2024)

    Fulltext@MSK | Save
  • A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2)
    Journal Article

    Lumish, M.; Chui, M. H.; Zhou, Q.; Iasonos, A.; Sarasohn, D.; Cohen, S.; Friedman, C.; Grisham, R.; Konner, J.; Kyi, C.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival
    Journal Article

    Kahn, R. M.; Selenica, P.; Boerner, T.; Roche, K. L.; Xiao, Y.; Sia, T. Y.; Maio, A.; Kemel, Y.; Sheehan, M.; Salo-Mullen, E.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Molecular characterization of endometrial carcinomas in black and white patients reveals disparate drivers with therapeutic implications
    Journal Article

    Weigelt, B.; Marra, A.; Selenica, P.; Rios-Doria, E.; Momeni-Boroujeni, A.; Berger, M. F.; Arora, K.; Nemirovsky, D.; Iasonos, A.; Chakravarty, D.; more...
    Cancer Discovery (2023)

    Fulltext@MSK | Save
  • Leave it in the past - Primary treatment modality for high-grade epithelial ovarian cancer is not associated with secondary cytoreduction outcomes: A Memorial Sloan Kettering Cancer Center Team Ovary study
    Journal Article

    Sia, T. Y.; Manning-Geist, B. L.; Ehmann, S.; Lavery, J. A.; Luardo, C.; Praiss, A.; Iasonos, A.; Sonoda, Y.; Grisham, R. N.; Liu, Y. L.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma
    Journal Article

    Rios-Doria, E.; Momeni-Boroujeni, A.; Friedman, C. F.; Selenica, P.; Zhou, Q.; Wu, M.; Marra, A.; Leitao, M. M. Jr; Iasonos, A.; Alektiar, K. M.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Impact of immune infiltration signatures on prognosis in endometrial carcinoma is dependent on the underlying molecular subtype
    Journal Article

    Dessources, K.; Ferrando, L.; Zhou, Q. C.; Iasonos, A.; Abu-Rustum, N. R.; Reis-Filho, J. S.; Riaz, N.; Zamarin, D.; Weigelt, B.
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combination
    Journal Article

    Kahn, R. M.; Ragupathi, G.; Zhou, Q. C.; Iasonos, A.; Kravetz, S.; Hensley, M. L.; Konner, J. A.; Makker, V.; Tew, W. P.; Aghajanian, C.; more...
    Cancer Immunology, Immunotherapy (2023)

    Fulltext@MSK | Save
  • Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: Going to the next level – A Memorial Sloan Kettering Cancer Center team ovary study
    Journal Article

    Kahn, R. M.; McMinn, E.; Yeoshoua, E.; Boerner, T.; Zhou, Q.; Iasonos, A.; Long Roche, K.; Zivanovic, O.; Gardner, G. J.; Sonoda, Y.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study
    Journal Article

    Rubinstein, M. M.; Doria, E. R.; Konner, J.; Lichtman, S.; Zhou, Q.; Iasonos, A.; Sarasohn, D.; Troso-Sandoval, T.; Friedman, C.; O'Cearbhaill, R.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save